organization · Reporting owner
AEON Biopharma, Inc.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Evolus, Inc.
Report date January 08, 2020 · Filed January 10, 2020
Section 16 reporting ended · disclosed 2020-01-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-01-08 transaction · row 1
1 source rowRow 1 · 2020-01-08 · Other · Disposed 8,662,346 · Balance 0 F1: Pursuant to a Contribution Agreement dated January 8, 2020, by and between the Reporting Person (formerly known as Alphaeon Corporation) and Alphaeon 1 LLC ("Alphaeon"), on January 8, 2020, the Reporting Person contributed 8,662,346 shares of the Issuer to Alphaeon (the "Contribution"). The shares of the Issuer contributed to Alphaeon are deemed "restricted securities" under Rule 144 promulgated under the Securities Act of 1933, as amended. At the time of the Contribution, Alphaeon was a wholly-owned subsidiary of the Reporting Person. Immediately after the Contribution, the Reporting Person distributed out all of the membership interests of Alphaeon to its stockholders. The Reporting Person is filing this exit Form 4 to report that it is no longer a beneficial owner of the Issuer's securities. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to a Contribution Agreement dated January 8, 2020, by and between the Reporting Person (formerly known as Alphaeon Corporation) and Alphaeon 1 LLC ("Alphaeon"), on January 8, 2020, the Reporting Person contributed 8,662,346 shares of the Issuer to Alphaeon (the "Contribution"). The shares of the Issuer contributed to Alphaeon are deemed "restricted securities" under Rule 144 promulgated under the Securities Act of 1933, as amended. At the time of the Contribution, Alphaeon was a wholly-owned subsidiary of the Reporting Person. Immediately after the Contribution, the Reporting Person distributed out all of the membership interests of Alphaeon to its stockholders. The Reporting Person is filing this exit Form 4 to report that it is no longer a beneficial owner of the Issuer's securities.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 08, 2020 Filed Jan 10, 2020 21:10 UTC | Evolus, Inc. EOLS · Entity 5341 | OtherCommon Stock | 8,662,346 | $0.00 | $0.00 |
DisclosureSEC source: 0001078782-20-000010 · primary_doc.xml · nonDerivative · entry 1 AEON Biopharma, Inc. · CIK 0001622667 · Former 10% Owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to a Contribution Agreement dated January 8, 2020, by and between the Reporting Person (formerly known as Alphaeon Corporation) and Alphaeon 1 LLC ("Alphaeon"), on January 8, 2020, the Reporting Person contributed 8,662,346 shares of the Issuer to Alphaeon (the "Contribution"). The shares of the Issuer contributed to Alphaeon are deemed "restricted securities" under Rule 144 promulgated under the Securities Act of 1933, as amended. At the time of the Contribution, Alphaeon was a wholly-owned subsidiary of the Reporting Person. Immediately after the Contribution, the Reporting Person distributed out all of the membership interests of Alphaeon to its stockholders. The Reporting Person is filing this exit Form 4 to report that it is no longer a beneficial owner of the Issuer's securities. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 23:40 UTC Amendment | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 1,298,701 | $19.25 | $24,999,994.25 |
DisclosureSEC source: 0001078782-19-000500 · primary_doc.xml · nonDerivative · entry 1 Alphaeon Corp · CIK 0001622667 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,662,346 F1 · kind: The acquisition of the shares of common stock referenced in this Form 4 was conducted in a private transaction between ALPHAEON Corporation ("ALPHAEON") and Strathspey Crown Holdings Group, LLC ("SCH"). SCH is a majority shareholder of ALPHAEON. The shares of common stock received by SCH are deemed "restricted securities" under Rule 144 promulgated under the Securities Act of 1933, as amended. F1 · shares: The acquisition of the shares of common stock referenced in this Form 4 was conducted in a private transaction between ALPHAEON Corporation ("ALPHAEON") and Strathspey Crown Holdings Group, LLC ("SCH"). SCH is a majority shareholder of ALPHAEON. The shares of common stock received by SCH are deemed "restricted securities" under Rule 144 promulgated under the Securities Act of 1933, as amended. F1 · price: The acquisition of the shares of common stock referenced in this Form 4 was conducted in a private transaction between ALPHAEON Corporation ("ALPHAEON") and Strathspey Crown Holdings Group, LLC ("SCH"). SCH is a majority shareholder of ALPHAEON. The shares of common stock received by SCH are deemed "restricted securities" under Rule 144 promulgated under the Securities Act of 1933, as amended. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 23:03 UTC | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 1,298,701 | $19.25 | $24,999,994.25 |
DisclosureSEC source: 0001078782-19-000499 · primary_doc.xml · nonDerivative · entry 1 Alphaeon Corp · CIK 0001622667 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,662,346 Read SEC document |
| May 22, 2019 Filed May 22, 2019 23:04 UTC | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 290,518 | $19.25 | $5,592,471.50 |
DisclosureSEC source: 0001078782-19-000477 · primary_doc.xml · nonDerivative · entry 3 Alphaeon Corp · CIK 0001622667 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,961,047 F1 · kind: The disposition of an aggregate of 1,307,940 shares of common stock was made pursuant to a private transaction with certain of Alphaeon Corporation's existing noteholders who elected to receive payment of certain outstanding amounts under their notes due June 23, 2019 in the form of shares of common stock rather than cash. The shares of common stock received by the noteholders are deemed "restricted securities" under Rule 144 promulgated under the Securities Act of 1933, as amended. Read SEC document |
| May 20, 2019 Filed May 22, 2019 23:04 UTC | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 1,017,422 | $19.25 | $19,585,373.50 |
DisclosureSEC source: 0001078782-19-000477 · primary_doc.xml · nonDerivative · entry 2 Alphaeon Corp · CIK 0001622667 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,251,565 F1 · kind: The disposition of an aggregate of 1,307,940 shares of common stock was made pursuant to a private transaction with certain of Alphaeon Corporation's existing noteholders who elected to receive payment of certain outstanding amounts under their notes due June 23, 2019 in the form of shares of common stock rather than cash. The shares of common stock received by the noteholders are deemed "restricted securities" under Rule 144 promulgated under the Securities Act of 1933, as amended. Read SEC document |
| May 20, 2019 Filed May 22, 2019 23:04 UTC | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 4,000,000 | $19.25 | $77,000,000.00 |
DisclosureSEC source: 0001078782-19-000477 · primary_doc.xml · nonDerivative · entry 1 Alphaeon Corp · CIK 0001622667 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,268,987 Read SEC document |
| November 29, 2018 Filed Dec 3, 2018 21:07 UTC | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 573,888 | $14.00 | $8,034,432.00 |
DisclosureSEC source: 0001078782-18-001389 · primary_doc.xml · nonDerivative · entry 1 Alphaeon Corp · CIK 0001622667 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,268,987 Read SEC document |
| September 11, 2018 Filed Sep 13, 2018 16:31 UTC | Evolus, Inc. EOLS) · Entity 5341 | SaleCommon Stock | 1,750,000 | $21.04 | $36,820,000.00 |
DisclosureSEC source: 0001078782-18-000975 · primary_doc.xml · nonDerivative · entry 1 Alphaeon Corp · CIK 0001622667 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,842,875 Read SEC document |
| July 23, 2018 Filed Jul 23, 2018 20:01 UTC | Evolus, Inc. EOLS · Entity 5341 | SaleCommon Stock | 1,000,000 | $18.80 | $18,800,000.00 |
DisclosureSEC source: 0001570562-18-000094 · wf-form4_153237608581846.xml · nonDerivative · entry 1 Alphaeon Corp · CIK 0001622667 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,592,875 F1 · kind: The Reporting Persons sold shares to the underwriters in connection with the closing of the Issuer's follow-on public offering. The reported sale price reflects the price at which the Reporting Persons sold shares to the underwriters, which is net of underwriting commissions. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 01:08 UTC | Evolus, Inc. EOLS · Entity 5341 | ConversionSeries A Preferred Stock · Derivative | 1,250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-18-001613 · wf-form4_151857049936322.xml · derivative · entry 2 Alphaeon Corp · CIK 0001622667 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,065,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Effective immediately upon the closing of the Issuer's initial public offering of its common stock under the Securities Act of 1933, as amended, each share of Series A preferred stock automatically converted into 1.6527 shares of the Issuer's common stock. The Series A preferred stock had no expiration date. F2 · derivative.exercise_date: Effective immediately upon the closing of the Issuer's initial public offering of its common stock under the Securities Act of 1933, as amended, each share of Series A preferred stock automatically converted into 1.6527 shares of the Issuer's common stock. The Series A preferred stock had no expiration date. F2 · derivative.expiration_date: Effective immediately upon the closing of the Issuer's initial public offering of its common stock under the Securities Act of 1933, as amended, each share of Series A preferred stock automatically converted into 1.6527 shares of the Issuer's common stock. The Series A preferred stock had no expiration date. F1 · derivative.underlying_shares: Reflects a 1.6527-for-1 forward stock split of the Issuer's common stock effected on January 26, 2018. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 01:08 UTC | Evolus, Inc. EOLS · Entity 5341 | ConversionCommon Stock | 2,065,875 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-18-001613 · wf-form4_151857049936322.xml · nonDerivative · entry 1 Alphaeon Corp · CIK 0001622667 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,065,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects a 1.6527-for-1 forward stock split of the Issuer's common stock effected on January 26, 2018. F2 · price: Effective immediately upon the closing of the Issuer's initial public offering of its common stock under the Securities Act of 1933, as amended, each share of Series A preferred stock automatically converted into 1.6527 shares of the Issuer's common stock. The Series A preferred stock had no expiration date. F1 · balance_after: Reflects a 1.6527-for-1 forward stock split of the Issuer's common stock effected on January 26, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.